F Grignani

19.1k total citations · 4 hit papers
172 papers, 14.9k citations indexed

About

F Grignani is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, F Grignani has authored 172 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 64 papers in Hematology and 33 papers in Immunology. Recurrent topics in F Grignani's work include Retinoids in leukemia and cellular processes (53 papers), Acute Myeloid Leukemia Research (46 papers) and Immune Cell Function and Interaction (18 papers). F Grignani is often cited by papers focused on Retinoids in leukemia and cellular processes (53 papers), Acute Myeloid Leukemia Research (46 papers) and Immune Cell Function and Interaction (18 papers). F Grignani collaborates with scholars based in Italy, United States and France. F Grignani's co-authors include Ildo Nicoletti, Carlo Riccardi, Maria Cristina Pagliacci, Graziella Migliorati, Pier Giuseppe Pelicci, Myriam Alcalay, Fausto Grignani, M Fagioli, C Peschle and Clara Nervi and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

F Grignani

170 papers receiving 14.6k citations

Hit Papers

A rapid and simple method for measuring thymocyte apoptos... 1991 2026 2002 2014 1991 1992 1998 1993 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Grignani Italy 50 10.2k 4.1k 3.0k 2.2k 1.8k 172 14.9k
Ugo Testa Italy 68 8.7k 0.9× 4.9k 1.2× 3.7k 1.3× 3.0k 1.4× 2.7k 1.4× 423 16.9k
Ildo Nicoletti Italy 37 6.9k 0.7× 1.7k 0.4× 2.4k 0.8× 1.9k 0.9× 999 0.5× 101 11.6k
Walter N. Hittelman United States 62 7.4k 0.7× 1.7k 0.4× 984 0.3× 3.8k 1.7× 2.5k 1.3× 223 12.2k
Salvatore V. Pizzo United States 71 7.5k 0.7× 3.2k 0.8× 2.8k 0.9× 2.0k 0.9× 3.7k 2.0× 395 17.2k
Agostino Tafuri Italy 36 4.3k 0.4× 2.0k 0.5× 2.3k 0.8× 1.7k 0.8× 787 0.4× 160 8.3k
Jordan U. Gutterman United States 63 4.8k 0.5× 4.0k 1.0× 4.5k 1.5× 5.4k 2.5× 1.2k 0.7× 312 16.2k
David M. Hockenbery United States 50 10.5k 1.0× 897 0.2× 3.2k 1.1× 3.6k 1.7× 2.1k 1.1× 124 16.7k
James A. McCubrey United States 79 16.1k 1.6× 2.6k 0.6× 3.2k 1.1× 6.8k 3.1× 3.9k 2.1× 421 24.9k
Douglas V. Faller United States 57 7.3k 0.7× 1.7k 0.4× 2.2k 0.7× 2.5k 1.1× 1.8k 1.0× 277 13.6k
Leonidas C. Platanias United States 76 9.0k 0.9× 2.4k 0.6× 7.4k 2.5× 6.9k 3.2× 2.8k 1.5× 340 18.6k

Countries citing papers authored by F Grignani

Since Specialization
Citations

This map shows the geographic impact of F Grignani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Grignani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Grignani more than expected).

Fields of papers citing papers by F Grignani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Grignani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Grignani. The network helps show where F Grignani may publish in the future.

Co-authorship network of co-authors of F Grignani

This figure shows the co-authorship network connecting the top 25 collaborators of F Grignani. A scholar is included among the top collaborators of F Grignani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Grignani. F Grignani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Costantini, Claudio, Stefano Brancorsini, F Grignani, Luigina Romani, & Marina Maria Bellet. (2025). Circadian metabolic adaptations to infections. Philosophical Transactions of the Royal Society B Biological Sciences. 380(1918). 20230473–20230473. 1 indexed citations
2.
Billi, Monia, et al.. (2024). Nuclear miRNAs: Gene Regulation Activities. International Journal of Molecular Sciences. 25(11). 6066–6066. 18 indexed citations
3.
Ricciuti, Biagio, Giulia C. Leonardi, Giulio Metro, et al.. (2015). Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications. Expert Review of Respiratory Medicine. 10(1). 53–68. 52 indexed citations
4.
Fazi, Francesco, Serena Racanicchi, Giuseppe Zardo, et al.. (2007). Epigenetic Silencing of the Myelopoiesis Regulator microRNA-223 by the AML1/ETO Oncoprotein. Cancer Cell. 12(5). 457–466. 301 indexed citations
5.
Racanicchi, Serena, Vania Gelmetti, Maddalena Panigada, et al.. (2005). Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells. The EMBO Journal. 24(10). 1899–1899. 1 indexed citations
6.
Grignani, F, Vania Gelmetti, Mirco Fanelli, et al.. (1999). Formation of PML/RARα high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RARα-mediated retinoic acid response. Oncogene. 18(46). 6313–6321. 37 indexed citations
7.
Testa, Ugo, F Grignani, P Samoggia, et al.. (1998). The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.. Journal of Clinical Investigation. 101(10). 2278–2289. 26 indexed citations
8.
Ferrucci, Pier Francesco, F Grignani, Mark Pearson, et al.. (1997). Cell death induction by the acute promyelocytic leukemia-specific PML/RARα fusion protein. Proceedings of the National Academy of Sciences. 94(20). 10901–10906. 55 indexed citations
10.
Liberati, A. M., Michel A. Horisberger, Lucia Palmisano, et al.. (1992). Double-Blind Randomized Phase I Study on the Clinical Tolerance and Biological Effects of Natural and Recombinant Interferon-β. Journal of Interferon Research. 12(5). 329–336. 26 indexed citations
12.
Alimena, Giuliana, Enrica Morra, Mario Lazzarino, et al.. (1991). IL TRATTAMENTO DELLA LEUCEMIA MIELOIDE CRONICA (LMC) CON INTERFERONE ∅-2B (IFN ∅2B). Haematologica. 76. 50. 1 indexed citations
13.
Spinozzi, Fabrizio, A Bertotto, Francesco Rondoni, et al.. (1991). T-lymphocyte activation pathways in alcoholic liver disease.. PubMed. 73(2). 140–6. 40 indexed citations
14.
Grignani, F, et al.. (1987). Genotypic, phenotypic, and functional aspects of haematopoiesis. Raven Press eBooks. 9 indexed citations
15.
Pagliacci, Maria Cristina, Giuliana Pelicci, F Grignani, et al.. (1987). Thyroid Function Tests in Patients Undergoing Maintenance Dialysis: Characterization of the <sup>‘</sup>Low-T<sub>4</sub> Syndrome’ in Subjects on Regular Hemodialysis and Continuous Ambulatory Peritoneal Dialysis. ˜The œNephron journals/Nephron journals. 46(3). 225–230. 21 indexed citations
16.
Seremetis, Stephanie, Pier Giuseppe Pelicci, Antonio Tabilio, et al.. (1987). High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase.. The Journal of Experimental Medicine. 165(6). 1703–1712. 81 indexed citations
17.
Puxeddu, A, et al.. (1986). Generalized sarcoid-type reaction associated with non-Hodgkin's lymphoma.. PubMed. 71(3). 225–8. 1 indexed citations
18.
Mandelli, Franco, Sergio Amadori, F Grignani, et al.. (1979). Treatment of acute nonlymphocytic leukemia (ANLL) in elderly patients. Results of a multicentric study.. PubMed. 64(3). 331–8. 1 indexed citations
19.
Palumbo, Renato, Maurizio Tonato, Maurizio Martelli, Simona Corso, & F Grignani. (1973). Gallium-67 citrate in the staging of malignant lymphomas.. PubMed. 17(3). 100–3. 3 indexed citations
20.
Grignani, F, et al.. (1958). [Premise, indications, possibility, limitations & mechanism of action of antidiabetic therapy with the new hypoglycemic derivatives of sulfonylurea].. PubMed. 49(15). 631–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026